- Dental sleep medicine, offering non-invasive oral appliance therapy (OAT) for sleep-disordered breathing such as obstructive sleep apnea (OSA) and snoring, is becoming an increasingly vital component of modern sleep health and dental care services, especially in both clinical and home-based settings due to its improved patient compliance, comfort, and integration with sleep monitoring technologies
- The escalating demand for dental sleep medicine is primarily driven by the rising global prevalence of sleep-related disorders, growing awareness of the health risks associated with untreated OSA, and increased physician and dentist collaboration in sleep health management
- North America dominated the dental sleep medicine market with the largest revenue share of 42.8% in 2024, characterized by early adoption of oral appliance therapy, high diagnostic rates of OSA, and the strong presence of key industry players. The U.S. is experiencing substantial growth in dental sleep medicine, particularly within multidisciplinary sleep centers and dental sleep practices, fueled by favorable insurance coverage and increased physician referrals
- Asia-Pacific is expected to be the fastest-growing region in the dental sleep medicine market during the forecast period with a projected CAGR of 9.6%, owing to increasing urbanization, rising disposable incomes, improving healthcare infrastructure, and growing awareness of sleep disorders in countries such as China, India, and Japan
- The treatment segment dominated the dental sleep medicine market with a revenue share of 63.7% in 2024, driven by the rising demand for therapeutic interventions such as Positive Airway Pressure (PAP) therapy and oral devices, which offer effective and patient-compliant solutions for managing sleep-related breathing disorders
